‘Aspects of Modern Drug Discovery’ – Speaker Summaries

The first guest speaker to take to the podium at Sygnature’s symposium on October 7th 2014, was Dr Jonathan Rachman from MapMy Health. In the early 1990s, a small group of academic units around the world was taking an interest in the physiological effects of the gut hormone glucagon-like peptide-1 (GLP-1), with a view to […]

Sygnature Celebrates 10 Years of Drug Discovery

On Tuesday 7th October 2014 Sygnature Discovery celebrated its 10th anniversary by hosting a symposium on ‘Aspects of Modern Drug Discovery’. Held at Nottingham’s East Midlands Conference Centre, seven distinguished scientific speakers were invited to talk to a packed audience of two hundred guests. The event came to a close with a drinks reception to […]

BerGenBio granted a prestigious Wellcome Trust Seeding Drug Discovery Award

NOK 16 million awarded to develop novel cancer Bergen, Norway, September 23, 2014 – BerGenBio AS (“BerGenBio” or the “Company”), an oncology biopharmaceutical company, today announces it has been granted a £1.6 million (NOK 16 million) Seeding Drug Discovery Award from the UK’s Wellcome Trust to develop novel small molecule inhibitors against BGB002, its proprietary, […]

Sygnature Discovery appoints Dr Gerry Thomas as Director of Business Development

Nottingham, UK – 24th April 2014 – Sygnature Discovery Limited, the UK’s largest independent integrated drug discovery provider, today announced the appointment of Dr Gerry Thomas to the pivitol role of Director of Business Development. Board Director, Dr Paul Clewlow, stated, “I am delighted to welcome Gerry Thomas to Sygnature Discovery. Gerry is a very […]

Page 14 of 14« First...1011121314
Copyright © 2017 Sygnature Discovery

Website built by AtomicMedia - Design by Freestyle.